Rituximab-Pfizer (PF-05280586) x 3 courses

( DrugBank: Rituximab / KEGG DRUG: Rituximab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01643928 (ClinicalTrials.gov)	August 16, 2012	6/7/2012	Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials ...	EXTENSION STUDY EVALUATING TREATMENT WITH PF-05280586 VERSUS RITUXIMAB IN SUBJECTS WITH ACTIVE RHEUM ...	Rheumatoid Arthritis	Biological: Rituximab-Pfizer (PF-05280586) x 3 courses;Biological: Rituximab-EU+ Rituximab-Pfizer x ...	Pfizer	NULL	Completed	18 Years	N/A	All	185	N/A	United States;Australia;Canada;Colombia;Germany;Israel;Mexico;Russian Federation;South Africa;United ...

First Previous1Next Last